NCT06808386

Brief Summary

This clinical trial aims to determine the optimal frequency of exercise therapy for improving pain, function, and quality of life in participants with patellofemoral pain. The main questions it aims to answer are: Does exercising twice a week provide the same benefits as exercising three times a week for individuals with patellofemoral pain? What are the optimal dosage, volume, and weekly exercise frequency for treating patellofemoral pain? The investigators will compare two groups of participants: one group of participants receiving exercise therapy twice a week and another group receiving exercise therapy three times a week. Both groups will follow the same exercise protocol targeting the muscles of the hip and knee joints. Participants: 84 volunteers (both male and female) with patellofemoral pain Physically active individuals aged between 18 and 40 years Interventions: Participants will be randomly assigned to one of two groups Both groups will perform the same exercises for hip and knee muscle strengthening Group A will exercise three times per week Group B will exercise two times per week The intervention will last for six consecutive weeks Assessments: Participants will be evaluated at the following time points: Before the intervention After the 4th and 6th week of intervention 6 months and 1 year after the end of the intervention The primary Outcome Measure will be pain intensity. Secondary Outcome Measure: Anterior knee pain during daily activities Kinesiophobia Pain-related self-efficacy Chronic pain-related self-efficacy Catastrophizing Muscle strength 3D Movement analysis Data Analysis: The investigators will use an intention-to-treat analysis, which means that all participants will be included in the study, regardless of whether they completed the treatment as planned. Appropriate statistical tests will be used to compare differences within and between the two groups, considering the time points and group factors. A 5% significance level will be adopted, which means there is a 5% chance that the results are due to random variation rather than the treatment effect.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
84

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Feb 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress66%
Feb 2025Dec 2026

First Submitted

Initial submission to the registry

January 28, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 5, 2025

Completed
19 days until next milestone

Study Start

First participant enrolled

February 24, 2025

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2026

Expected
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2026

Last Updated

February 5, 2025

Status Verified

February 1, 2025

Enrollment Period

1.8 years

First QC Date

January 28, 2025

Last Update Submit

February 4, 2025

Conditions

Keywords

Patellofemoral PainExercise TherapyDose-ResponseMusculoskeletal Pain

Outcome Measures

Primary Outcomes (1)

  • Pain intensity

    Visual Analog Pain Scale: This scale aims to quantify the intensity of pain experienced by the patient. The scale consists of 11 points, with a score classification from 0 to 10. A score of 0 represents "no pain at all", and 10 means "the worst pain possible". Patients will be asked to rate their anterior knee pain intensity levels based on the past fifteen days. The minimum clinically important difference for improvement will be a decrease of 1 point on the scale.

    Evaluations will occur at five time frames: 24 hours before the first treatment session, after the 4th and 6th weeks of treatment, and 6 months and 1 year after the last session.

Secondary Outcomes (8)

  • Anterior Knee Pain Scale

    24 hours before the first treatment session, after the 4th and 6th weeks of treatment, and 6 months and 1 year after the last session.

  • Tampa Scale for Kinesiophobia

    24 hours before the first treatment session, after the 4th and 6th weeks of treatment, and 6 months and 1 year after the last session.

  • Pain Self-Efficacy Questionnaire

    24 hours before the first treatment session, after the 4th and 6th weeks of treatment, and 6 months and 1 year after the last session.

  • Chronic Pain Self-Efficacy Scale

    24 hours before the first treatment session, after the 4th and 6th weeks of treatment, and 6 months and 1 year after the last session.

  • Pain Catastrophizing Scale

    24 hours before the first treatment session, after the 4th and 6th weeks of treatment, and 6 months and 1 year after the last session.

  • +3 more secondary outcomes

Study Arms (2)

Strengthening 2 times per week

EXPERIMENTAL

This group will consist of participants with patellofemoral pain and will receive treatment twice a week.

Other: Strengthening 2 times per week

Strengthening 3 times per week

OTHER

This group will consist of participants with patellofemoral pain and will receive treatment twice a week.

Other: Strengthening 3 times per week

Interventions

This group will consist of participants with patellofemoral pain and will receive treatment twice a week.

Strengthening 2 times per week

This group will consist of participants with patellofemoral pain and will receive treatment thrice a week.

Strengthening 3 times per week

Eligibility Criteria

Age18 Years - 40 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nove de Julho University

São Paulo, São Paulo, 01.504-001, Brazil

Location

MeSH Terms

Conditions

Patellofemoral Pain SyndromeMusculoskeletal Pain

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesMuscular DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • PAULO RG LUCARELI, PhD

    Nove de Julho University

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Human Movement Analysis Laboratory

Study Record Dates

First Submitted

January 28, 2025

First Posted

February 5, 2025

Study Start

February 24, 2025

Primary Completion (Estimated)

November 30, 2026

Study Completion (Estimated)

December 21, 2026

Last Updated

February 5, 2025

Record last verified: 2025-02

Data Sharing

IPD Sharing
Will not share

Locations